Nitric oxide inhibits an interaction between JNK1 and c-Jun through nitrosylation

Biochemical and Biophysical Research Communications

Volumn 351, Issue 1, 2006, Pages 281-286

  Park, Hee Sae ^a   Mo, Jung Soon ^a   Choi, Eui Ju ^b  

^a Chonnam National University   (South Korea)

^b Korea University   (South Korea)

Author keywords

c Jun; JNK; Nitrosylation; NO

Indexed keywords

ANISOMYCIN; DITHIOTHREITOL; GAMMA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PENICILLAMINE DERIVATIVE; S NITRO N ACETYLPENICILLAMINE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MICROGLIA; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KIDNEY; MICE; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASE 8; NITRIC OXIDE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION;

EID: 33750348549     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.10.034     Document Type: Article

References (59)

1. Arancio O., Kandel E.R., and Hawkins R.D. Activity-dependent long-term enhancement of transmitter release by presynaptic 3′,5′-cyclic GMP in cultured hippocampal neurons. Nature 376 (1995) 74-80
2. Dimmeler S., Haendeler J., Nehls M., and Zeiher A.M. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 185 (1997) 601-607
3. Kuzin B., Roberts I., Peunova N., and Enikolopov G. Nitric oxide regulates cell proliferation during Drosophila development. Cell 87 (1996) 639-649
4. Nathan C., and Xie Q.W. Nitric oxide synthases: roles, tolls, and controls. Cell 78 (1994) 915-918
5. Wang Y., and Marsden P.A. Nitric oxide synthases: gene structure and regulation. Adv. Pharmacol. 34 (1995) 71-90
6. Hattori R., Sase K., Eizawa H., Kosuga K., Aoyama T., Inoue R., Sasayama S., Kawai C., Yui Y., Miyahara K., et al. Structure and function of nitric oxide synthases. Int. J. Cardiol. 47 (1994) S71-S75
7. Sessa W.C. The nitric oxide synthase family of proteins. J. Vasc. Res. 31 (1994) 131-143
8. 2+/calmodulin-regulated nitric oxide synthases. Cell Calcium 13 (1992) 427-434
9. Lee S.C., and Brosnan C.F. Cytokine Regulation of iNOS Expression in Human Glial Cells. Methods 10 (1996) 31-37
10. Eizirik D.L., and Leijerstam F. The inducible form of nitric oxide synthase (iNOS) in insulin-producing cells. Diabetes Metab. 20 (1994) 116-122
11. Gao J., Morrison D.C., Parmely T.J., Russell S.W., and Murphy W.J. An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide. J. Biol. Chem. 272 (1997) 1226-1230
12. Alley E.W., Murphy W.J., and Russell S.W. A classical enhancer element responsive to both lipopolysaccharide and interferon-gamma augments induction of the iNOS gene in mouse macrophages. Gene 158 (1995) 247-251
13. Shi Y., and Gaestel M. In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance. Biol. Chem. 383 (2002) 1519-1536
14. Barr R.K., and Bogoyevitch M.A. The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs). Int. J. Biochem. Cell. Biol. 33 (2001) 1047-1063
15. Cano E., and Mahadevan L.C. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20 (1995) 117-122
16. Davis R.J. MAPKs: new JNK expands the group. Trends Biochem. Sci. 19 (1994) 470-473
17. Bradham C., and McClay D.R. p38 MAPK in development and cancer. Cell Cycle 5 (2006) 824-828
18. Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta 1754 (2005) 253-262
19. Fang J.Y., and Richardson B.C. The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 6 (2005) 322-327
20. Kolch W., Calder M., and Gilbert D. When kinases meet mathematics: the systems biology of MAPK signalling. FEBS Lett. 579 (2005) 1891-1895
21. Bogoyevitch M.A., Boehm I., Oakley A., Ketterman A.J., and Barr R.K. Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochim. Biophys. Acta 1697 (2004) 89-101
22. Gerthoffer W.T., and Singer C.A. MAPK regulation of gene expression in airway smooth muscle. Respir. Physiol. Neurobiol. 137 (2003) 237-250
23. Zhang W., and Liu H.T. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 12 (2002) 9-18
24. Hazzalin C.A., and Mahadevan L.C. MAPK-regulated transcription: a continuously variable gene switch?. Nat. Rev. Mol. Cell Biol. 3 (2002) 30-40
25. English J.M., and Cobb M.H. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol. Sci. 23 (2002) 40-45
26. Seger R., and Krebs E.G. The MAPK signaling cascade. FASEB J. 9 (1995) 726-735
27. Inglese J., Koch W.J., Touhara K., and Lefkowitz R.J. G beta gamma interactions with PH domains and Ras-MAPK signaling pathways. Trends Biochem. Sci. 20 (1995) 151-156
28. Shen K., and Novak R.F. DDT stimulates c-erbB2, c-met, and STATS tyrosine phosphorylation, Grb2-Sos association, MAPK phosphorylation, and proliferation of human breast epithelial cells. Biochem. Biophys. Res. Commun. 231 (1997) 17-21
29. Dumaz N., and Marais R. Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft fur Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels. FEBS J. 272 (2005) 3491-3504
30. Chang F., Steelman L.S., Lee J.T., Shelton J.G., Navolanic P.M., Blalock W.L., Franklin R.A., and McCubrey J.A. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17 (2003) 1263-1293
31. Hilger R.A., Scheulen M.E., and Strumberg D. The Ras-Raf-MEK-ERK pathway in the treatment of cancer. Onkologie 25 (2002) 511-518
32. Agell N., Bachs O., Rocamora N., and Villalonga P. Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin. Cell. Signal. 14 (2002) 649-654
33. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351 Pt. 2 (2000) 289-305
34. Marais R., and Marshall C.J. Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv. 27 (1996) 101-125
35. Adler V., Schaffer A., Kim J., Dolan L., and Ronai Z. UV irradiation and heat shock mediate JNK activation via alternate pathways. J. Biol. Chem. 270 (1995) 26071-26077
36. Chen Y.R., Wang X., Templeton D., Davis R.J., and Tan T.H. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem. 271 (1996) 31929-31936
37. Derijard B., Hibi M., Wu I.H., Barrett T., Su B., Deng T., Karin M., and Davis R.J. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76 (1994) 1025-1037
38. Han J., Lee J.D., Bibbs L., and Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265 (1994) 808-811
39. Rosette C., and Karin M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274 (1996) 1194-1197
40. Song H.Y., Regnier C.H., Kirschning C.J., Goeddel D.V., and Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA 94 (1997) 9792-9796
41. Derijard B., Raingeaud J., Barrett T., Wu I.H., Han J., Ulevitch R.J., and Davis R.J. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267 (1995) 682-685
42. Foltz I.N., Gerl R.E., Wieler J.S., Luckach M., Salmon R.A., and Schrader J.W. Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly conserved c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activated by environmental stresses and physiological stimuli. J. Biol. Chem. 273 (1998) 9344-9351
43. Holland P.M., Suzanne M., Campbell J.S., Noselli S., and Cooper J.A. MKK7 is a stress-activated mitogen-activated protein kinase kinase functionally related to hemipterous. J. Biol. Chem. 272 (1997) 24994-24998
44. Moriguchi T., Toyoshima F., Masuyama N., Hanafusa H., Gotoh Y., and Nishida E. A novel SAPK/JNK kinase, MKK7, stimulated by TNFalpha and cellular stresses. EMBO J. 16 (1997) 7045-7053
45. Nishina H., Fischer K.D., Radvanyi L., Shahinian A., Hakem R., Rubie E.A., Bernstein A., Mak T.W., Woodgett J.R., and Penninger J.M. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385 (1997) 350-353
46. Tournier C., Whitmarsh A.J., Cavanagh J., Barrett T., and Davis R.J. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc. Natl. Acad. Sci. USA 94 (1997) 7337-7342
47. Tournier C., Whitmarsh A.J., Cavanagh J., Barrett T., and Davis R.J. The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases. Mol. Cell. Biol. 19 (1999) 1569-1581
48. Yan M., Dai T., Deak J.C., Kyriakis J.M., Zon L.I., Woodgett J.R., and Templeton D.J. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 372 (1994) 798-800
49. Huang C., Jacobson K., and Schaller M.D. A role for JNK-paxillin signaling in cell migration. Cell Cycle 3 (2004) 4-6
50. Ip Y.T., and Davis R.J. Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development. Curr. Opin. Cell Biol. 10 (1998) 205-219
51. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912
52. Kanda H., and Miura M. Regulatory roles of JNK in programmed cell death. J. Biochem. (Tokyo) 136 (2004) 1-6
53. Kennedy N.J., and Davis R.J. Role of JNK in tumor development. Cell Cycle 2 (2003) 199-201
54. Lin A., and Dibling B. The true face of JNK activation in apoptosis. Aging Cell 1 (2002) 112-116
55. Nishina H., Wada T., and Katada T. Physiological roles of SAPK/JNK signaling pathway. J. Biochem. (Tokyo) 136 (2004) 123-126
56. Vlahopoulos S., and Zoumpourlis V.C. JNK: a key modulator of intracellular signaling. Biochemistry (Mosc.) 69 (2004) 844-854
57. Weston C.R., and Davis R.J. The JNK signal transduction pathway. Curr. Opin. Genet. Dev. 12 (2002) 14-21
58. Park H.S., Huh S.H., Kim M.S., Lee S.H., and Choi E.J. Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation. Proc. Natl. Acad. Sci. USA 97 (2000) 14382-14387
59. Park H.S., Lee J.S., Huh S.H., Seo J.S., and Choi E.J. Hsp72 functions as a natural inhibitory protein of c-Jun N-terminal kinase. EMBO J. 20 (2001) 446-456